AMSTERDAM (Reuters) – The European Medicines Agency (EMA) expects to hold a briefing on the possible side effects of the AstraZeneca coronavirus vaccine on Wednesday at 1600 CET (1400 GMT).
Experts from the European drug authority have reviewed to what extent some cases of blood clotting in adults who had recently received the AstraZeneca vaccine may be linked to the injections.
(Reporting by Bart Meijer; Editing by Hugh Lawson)
Prosecution witnesses say Chauvin disregarded training in deadly encounter with George Floyd
Transat’s top shareholder turns down Quebec businessman Peladeau’s offer – The Globe and Mail
U.S. SEC charges actor with operating $690 million Ponzi scheme
WHO says AstraZeneca benefits outweigh risks; assessing latest data
5 Key matchups to watch when the Eagles battle the Commanders for the NFC East crown
Sixers 2024 trade primer: What you need to know
Eagles History: More good than bad for Philly in Washington since 2000
Sixers head to Cleveland to take on first place Cavaliers
Saquon Barkley has a realistic path to breaking the NFL’s all-time single season rushing record
ROH Final Battle: Wrestling stars put on a wild clash at Manhattan’s Hammerstein Ballroom
Stella Cole: A vintage voice on capturing modern hearts and preparing for holiday shows
Mayor Adams highlights 2024 achievements as he gears up for a tough re-election campaign
Party City to go out of business for good: reports
Community organizations call on Hochul at City Hall to sign SAFE Shelter Act into law
